to manage essential and affordable medicines

STEP II: safe - risk assessment

This phase focuses on factors that could impact on safe use of the various products during routine use by patients. This risk assessment is carried out on both the packaging and instructions, to minimize difficulties for patients and help them safely and optimally use their medicines.

Information services / support

  • Reports of previous risk assessments
  • Validated methodology
  • Database linkage to procurement information
  • Consultancy: how previous risk assessments have been undertaken and how they can be re-applied in any specific setting.

Next step